Education
About Us
Working with TipRanks
Follow Us
Neural Therapeutics Inc. (TSE:NURL)
:NURL
NURL Stock Chart & Stats
C$0.02
--
Market closed
C$0.02
--
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.05
Previous CloseN/A
VolumeN/A
Average Volume (3M)331.48K
Market Cap
C$2.53M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.72
Next Earnings
Apr 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding168,700,500
10 Day Avg. Volume453,922
30 Day Avg. Volume331,483
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Neural Therapeutics Inc. News
NURL FAQ
What was Neural Therapeutics Inc.’s price range in the past 12 months?
Neural Therapeutics Inc. lowest stock price was C$0.01 and its highest was C$0.05 in the past 12 months.
What is Neural Therapeutics Inc.’s market cap?
Neural Therapeutics Inc.’s market cap is C$2.53M.
When is Neural Therapeutics Inc.’s upcoming earnings report date?
Neural Therapeutics Inc.’s upcoming earnings report date is Apr 06, 2026 which is in 84 days.
How were Neural Therapeutics Inc.’s earnings last quarter?
Currently, no data Available
Is Neural Therapeutics Inc. overvalued?
According to Wall Street analysts Neural Therapeutics Inc.’s price is currently Overvalued.
Does Neural Therapeutics Inc. pay dividends?
Neural Therapeutics Inc. does not currently pay dividends.
What is Neural Therapeutics Inc.’s EPS estimate?
Neural Therapeutics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neural Therapeutics Inc. have?
Neural Therapeutics Inc. has 168,700,500 shares outstanding.
What happened to Neural Therapeutics Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Neural Therapeutics Inc.?
Currently, no hedge funds are holding shares in TSE:NURL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Neural Therapeutics Inc.
Neural Therapeutics is an ethnobotanical drug discovery company, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. The Company's innovative approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy.
Technical Analysis
Wesana Health Holdings Inc
―
Braxia Scientific
―
HAVN Life Sciences
―
MYND Life Sciences
―
Lexston Life Sciences Corp.
―